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A B S T R A C T
Ocular function depends on a high level of anatomical integrity. This is threatened by inﬂammation, which alters
the local tissue over short and long time-scales. Uveitis due to autoimmune disease, especially when it involves
the retina, leads to persistent changes in how the eye interacts with the immune system. The normal pattern of
immune surveillance, which for immune privileged tissues is limited, is re-programmed. Many cell types, that are
not usually present in the eye, become detectable. There are changes in the tissue homeostasis and integrity. In
both human disease and mouse models, in the most extreme cases, immunopathological ﬁndings consistent with
development of ectopic lymphoid-like structures and disrupted angiogenesis accompany severely impaired eye
function. Understanding how the ocular environment is shaped by persistent inﬂammation is crucial to devel-
oping novel approaches to treatment.
1. Introduction
The immune response addresses an enormous variety of challenges
across many diﬀerent time-scales from acute viral illness, cleared
within a week, to chronic infections, like tuberculosis and herpes
viruses, that can remain dormant for decades. A key determinant of the
outcome is whether the infection can be eradicated: if it cannot, the
environment may be remodelled, to keep pathogens in check. Organ
systems demonstrate a wide range of tissue speciﬁc ﬂexibility in their
adaptations to changes in the environment (Hussell and Bell, 2014) and
part of this remodelling involves re-programming patterns of im-
munosurveillance. When the cause of chronic inﬂammation is not in-
fection but autoimmunity, elimination of the inciting antigen is often
incompatible with survival. Instead, in many cases, an uneasy com-
promise between the tissue and the immune system is evident, perhaps
punctuated by ﬂuctuations in the status of the local inﬂammation that
manifests clinically as remissions and relapses.
No organ system is exempt from the development of autoimmunity.
Immune privilege shapes the nature and tempo of immunosurveillance,
but all tissues submit to the demands of the immune system, to report
on their well-being and integrity. When these reports are unsatisfactory,
the consequences in terms of tissue damage are frequently profound.
And in addition to harm caused by acute inﬂammation, a previously
healthy tissue may be compelled in the long term to submit to much
more rigorous scrutiny than is customary.
Accommodating such change in tissues is a necessary requirement
for immune memory. The balance of importance between the central
mechanisms of immune memory, that provide recirculating eﬀectors
which target diseased tissue, and locally based immune responses is
diﬃcult to estimate. There is growing evidence that local tissue re-
sponses can play a critical role in defending an individual from re-
infection at speciﬁc sites (Schenkel and Masopust, 2014; Steinert et al.,
2015). It is also clear from recent work in animal models and human
disease, that the long-term local changes which occur are important
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contributors to the severity of disease. These eﬀects manifest across a
multiplicity of individual core functions including: immune tissue
neogenesis, angiogenesis, stromal remodelling and the local expression
of co-inhibitory molecules. Whether these represent individual in-
dependent modules, or an interlocking programmatic response is not
clear. But in diﬀerent diseases, therapeutically successful targeting of
these functions oﬀers a paradigm to intervene, with the goal of resetting
the inﬂammatory state of the tissue.
Autoimmune diseases in the eye capture many aspects of the process
in both the clinical setting and in disease models. Models have allowed
the dissection of the interplay between important core functions, while
the introduction of biologics into the clinic have helped establish the
close relationship in the underlying pathology between ocular disease
and diseases such as rheumatoid arthritis. Understanding the new
patterns of immunosurveillance that are consequent upon autoimmune
disease will be important for managing future immunotherapies.
2. New niches for immunosurveillance
2.1. Immune privilege & privileged niches
Our understanding of immune privilege has evolved over the se-
venty years since the concept was elaborated in seminal investigations
of skin grafts transplanted to diﬀerent tissues (Medawar, 1948). The
original notion of antigen sequestration behind anatomical barriers has
been revised, as the structures that provide lymph drainage from
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Fig. 1. Ocular inﬁltration by lymphocytes is comprised of a diverse population of cells.
(A) The prodrome is characterised by an initial slow localisation of cells to the eye, followed by rapid accumulation and secondary regulation. (B) Lymphocytes were prepared from the
vitreous, retina and ciliary tissue of C57BL/6 animals with acute EAU (day 23–25) and persistent disease (day 38–43). Populations of live CD45 positive, CD11b negative cells were
quantiﬁed by multiparameter ﬂow cytometry. Adapted from Kerr et al. (2008a,b) Prog. Retin. Eye Res. 27, 527–535 & Boldison et al. (2014). J Immunol 192, 4541–4550.
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privileged sites such as the brain have gradually come to be recognised
(Andres et al., 1987; Aspelund et al., 2015; Földi, 1966; Louveau et al.,
2015); the presence or absence of choroidal lymph drainage from the
healthy eye remains controversial (Chan-Ling et al., 2015; Heindl et al.,
2015; Koina et al., 2015; Schrodl et al., 2015; Schroedl et al., 2014), but
like the brain, autoimmunity in the eye connects to the rest of the
immune system (Alex et al., 2011; Xu et al., 2007).
Studies of human immune cells obtained from the CSF of subjects
that do not have CNS inﬂammation are a window on normal im-
munosurveillance of immune privileged tissue. They ﬁnd mainly CD4+
T cells of an eﬀector memory phenotype (Engelhardt and Ransohoﬀ,
2005; Kivisäkk et al., 2003); the reactivation of occult infections that
can arise in patients following blockade of immunosurveillance attests
to its importance in sustaining health (Wraith and Nicholson, 2012).
The special immunological status of the eye has been recognised
and exploited by many investigators over a number of years. This has
produced a large literature which has been extensively reviewed
(Niederkorn, 2006; Taylor, 2009). One striking feature is the ability of
the eye to respond to the inoculation of foreign cells with a systemic
immune deviation that suppresses delayed type hypersensitivity re-
sponses. This phenomenon is known as anterior chamber-associated
immune deviation (ACAID). Inoculation into the vitreous cavity has
similar eﬀects and this phenomenon is known as vitreous cavity-asso-
ciated immune deviation (Sonoda et al., 2005).
It is clear from animal models that ACAID depends on autonomic
innervation and leukocyte recirculation outside the eye for its induc-
tion; it is thought to limit bystander damage to from potentially in-
jurious activated immune cells (Lin et al., 2005; Niederkorn, 2006),
therefore having a physiological role in sustaining tissue integrity.
A more pressing concern of this monograph is whether and how
processes of immunosurveillance are modiﬁed once local inﬂammation
becomes established. Brain and eye tissues, though they are isolated
from the circulation by anatomical and functional barriers in health,
undergo profound local changes that are triggered by immune re-
sponses within the aﬀected tissue (Bechmann et al., 2007; Kerr et al.,
2008a; Zhou et al., 2012). In the context of models of ocular organ
speciﬁc autoimmunity, e.g experimental autoimmune uveitis (EAU), it
is feasible to demonstrate that this all plays out in a time frame that can
usefully be divided into diﬀerent phases. Disease is clinically silent
following initiation, for example by immunisation with autoantigen,
and although sensitive analysis in this phase demonstrates an increase
in leukocyte retention in the retina, this is antigen non-speciﬁc
(Prendergast et al., 1998) (Lait; unpublished data). Clinical disease
follows this prodrome, characterised by a large inﬂux of leukocytes that
rapidly reach a peak and then partially resolve. Subsequently there is an
indeﬁnite period of secondary regulation; in murine experimental
models the retina never returns to normal health (Chen et al., 2012;
Copland et al., 2008; Kerr et al., 2008a, 2008b; Wang et al., 2011).
Persistent inﬂammation is associated with retinal dysfunction and with
the development of niches that favour the retention immune cells in the
vicinity of the aﬀected tissue. Fig. 1 and Table 1 summarise the cell
content of these diﬀerent phases, elaborating on how an increasingly
rich and diverse set of immune cells can be obtained from the eye as
EAU develops.
The concept of niches that support cell survival developed from
ecology and was ﬁrst applied by cell biologists to hematopoietic stem
cells. A prescient paper published in 1978 (Schoﬁeld, 1978) proposed
that the basic characteristic of these niches would be a deﬁned
anatomy, containing stem cells that could be sustained and reproduce,
but which was constrained and therefore limited the maximum stem
cell population size (Papayannopoulou and Scadden, 2008). The ex-
tension of this framework to lymphocytes produced an elegant ap-
proach to analysing their survival and homeostasis, emphasised that
diﬀerent populations (for example naive versus memory cells) interact
with speciﬁc and diﬀerent niches, and highlighted competition for re-
sources as a key element of this process (Butcher and Picker, 1996;
Freitas and Rocha, 2000). This work was primarily concerned with
lymphocytes in the circulation and in secondary lymphoid tissue. The
description and deﬁnition of the resources that maintain memory cells
continues to play an important role in our developing understanding of
lymphocyte homeostasis (Sprent and Surh, 2011; Surh and Sprent,
2008). But advances in this area also demonstrated that for certain cell
types, the set point of homeostasis can be changed. Experiments
quantifying the population sizes of CD8+ memory cells (Vezys et al.,
2009), showed that the immune system has the capacity to re-program,
increase niche capacity, and change in response to infection.
Chronic inﬂammation of many kinds leads to profound changes in the
local anatomy and immune response. This has been described in nu-
merous tissues aﬀected by autoimmunity. In the synovium of patients
with rheumatoid arthritis, blood vessels develop lining cells, typical of
lymph node high endothelial venules (Jalkanen et al., 1986), that are
associated with the accumulation of helper-inducer T cells (Pitzalis et al.,
1988). The discovery of cytokines and chemokines that co-ordinate this
process, beginning with lymphotoxin (Cyster, 2014; Kratz et al., 1996)
led to the concept that the most extreme manifestation of this process
was lymphoid neogenesis: a recapitulation outside the immune system of
the development of structures associated with lymph nodes (Drayton
et al., 2006). Applying these principles to immune privileged tissues such
as the eye and brain was initially controversial, but there is now a strong
case that lymphoid follicles can develop in the in the cerebral meninges
of the central nervous system (CNS). In a study of post-mortem brain
tissue of patients with secondary progressive multiple sclerosis, the fol-
licles were found distributed throughout the forebrain, in the meninges
entering the cerebral sulci (Magliozzi et al., 2007; Seraﬁni et al., 2004).
This was associated with severe cortical demyelination in adjacent tissue
and also with poor clinical outcome (Howell et al., 2011). Follicles have
also been shown to develop in animal models of MS, where this process is
driven by Th17 cells (Peters et al., 2011). Here cells were reported to be
in the spinal cord sub-arachnoid space. Therefore, immune privilege is no
bar to immune system tissue re-programming, although it may modify its
manifestations.
The chronic inﬂammatory process in the retina resembles that in the
CNS, in that it occurs behind the blood retinal barrier (BRB) in an
immune privileged environment. Non-infectious human uveitis presents
as a heterogeneous group of diseases, some of which have an under-
lying autoimmune aetiology (Caspi, 2010; Forrester et al., 2013; Lee
et al., 2014). Its animal model, experimental autoimmune uveitis (EAU)
correlates well with many of the pathological features that are seen in
Table 1
Leukocyte content at diﬀerent phases of EAU.
Cell population Mouse strain Normal* Prodrome** Peak Secondary regulation***
CD11b+ cells B10.RIII 660 ± 50 1050 ± 100 104,000 ± 26,800 4980 ± 2110
C57BL/6 700 ± 30 1400 ± 130 21,730 ± 3880 18,640 ± 4250
CD4+ lymphocytes B10.RIII 25 ± 5 120 ± 15 23,500 ± 5700 3870 ± 1230
C57BL/6 20 ± 2 215 ± 20 15,340 ± 2950 17,290 ± 3500
CD8+ lymphocytes C57BL/6 2320 ± 440 4640 ± 810
Cells were prepared from the vitreous, retina and ciliary body from normal animals or animals with EAU and quantiﬁed as described (Boldison et al., 2014; Kerr et al., 2008b).
*Mean ± standard error. Data from 17 or more eyes except B10.RIII peak disease from 7 eyes. **Data pooled from days 5–7; ***Data pooled from days 34–44. Data from (Boldison et al.,
2014; Kerr et al., 2008b) and J. Boldison & P. Lait unpublished.
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these human diseases (Copland et al., 2008). T cell receptor (TCR)
transgenesis, with retinal autoantigen speciﬁc TCR can drive lymphoid
neogenesis in the mouse retina (Kielczewski et al., 2016), while in the
human eye, tissue obtained from individuals with a history of persistent
uveitis, follicles are seen in about 20% of cases (Fig. 2; S. Epps et al.
unpublished data).
In the animal model, disease is most often induced by active im-
munisation using retinal speciﬁc antigens and adjuvants, or by the
transfer of antigen speciﬁc T cells, though other models have also been
used (Caspi, 2010; Kerr et al., 2008a; Zhou et al., 2012). The common
use of adjuvants in these models may lead to concurrent para-in-
ﬂammatory reactions to infections components (Forrester et al., 2013;
Xu et al., 2009). Studies of EAU often focus on the acute phase of the
response, but although EAU has been described as monophasic, sensi-
tive analyses of the disease in the mouse has demonstrated that while
the tempo of inﬂammation it is less after the primary peak of in-
ﬂammation it remains a dynamic process, furthermore the immune
content and immunosurveillance of the tissue is radically altered by the
disease (Kerr et al., 2008b) and subsequent studies have conﬁrmed and
extended this observation (Chen et al., 2012; Chu et al., 2013; Oh et al.,
2011). How these long-term changes over months in mice relate to
chronic burnt-out disease in humans requires further exploration.
Because the normal eye contains few lymphocytes, quantifying cell
content as EAU develops following immunisation can be used to iden-
tify the disease prodrome. This is followed by an exponential increase in
the leukocyte content of the eye, which deﬁnes a primary peak of dis-
ease, and elevated immune cell numbers continue to be measurable
through an extended period of secondary regulation (Fig. 1 and
Table 1). Diﬀerences are observed between mouse strains, with B10.RIII
mice recruiting more cells to the eye at peak disease but having a lower
cell content during secondary regulation; the opposite pattern is seen in
the C57BL/6 strain (Table 1). In the majority of animals, disease status
assessed by clinical examination or cell content is comparable in both
eyes, but in a signiﬁcant minority (about 18%), disease may be dis-
cordant between individual eyes for an extended period of time (J.
Boldison, T Khera unpublished data). This demonstrates a degree of
local tissue independence in how pathology manifests, highlighting that
the immune response incorporates a negotiation between systemic
immunosurveillance and local immune regulation. This may also in-
form our ﬁndings in human disease that follicle maturation occurs with
diﬀerent kinetics in the same eye (see below).
In C57BL/6 animals the dynamics of CD4+ T cell recruitment, which
peak early, is diﬀerent from that of CD8+ T cells (and B220 positive and
NK 1.1 positive cells) which accumulate during secondary regulation
between 3 and 6 weeks after the induction of uveitis (Boldison et al.,
2014), reaching higher cell densities than are seen at the peak of disease,
densities that are maintained for an extended period (at least until day
120 after disease induction - J. Boldison, M. Stimpson unpublished data).
This indicates continuous shaping of the local microenvironment as the
disease progresses. At later time points (days 60–90) C57BL/6 mice also
develop retinal neovascular membranes as a result of a persistent an-
giogenic process (Chen et al., 2012). These ﬁndings emphasise the
evolving nature of persistent inﬂammation in EAU and imply that one
result of local autoimmunity is a change in the capacity of the immune
privileged tissue to retain populations of immune cells; the tissue has
developed new niches that immune cells can inhabit.
2.2. Impact on retinal function
Uveitis is a signiﬁcant burden on retinal tissue and glia-neuron in-
teractions play a key role in health and disease (Vecino et al., 2016).
Massive gliosis is one non-speciﬁc response, that is induced by many
diﬀerent ocular insults, including persistent inﬂammation (Nork et al.,
1986; Yanoﬀ et al., 1971). It has long been recognised in experimental
Fig. 2. Lymphocyte populations in human uveitis. Lesions
stained with diﬀerent markers of leukocyte phenotype are
shown.
(A) Immunohistochemistry of the choroid of a 29 year old
woman with persistent non-infectious uveitis (Idiopathic
uveitis) demonstrating diﬀerent lymphocyte populations.
(B) Serial section of a single lesion showing follicle like
structure in human uveitis. Immunohistochemistry images
of the choroid of a 28 year old woman with persistent non-
infectious uveitis (scleritis, episcleritis and uveitis) de-
monstrating features of ectopic lymphoid-like structures: T
cells surrounding B cells and evidence of active re-
combination (BCL6+ and AID + cells.) In both cases en-
ucleation was carried out a for blind painful eye, late in the
disease process. Photomicrographs show T cells (CD3+,
CD4+ and CD8+), B cells (CD20+), Follicular B cells
(CD23+), Plasma cells (CD138), Follicular Dendritic Cells
(CD21+) and macrophage/monocytes (CD68+).
Granulomas were not identiﬁed in these specimens. All
images ×400 magniﬁcation.
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uveitis in both rodents and primates (Chan et al., 1991; Fujino et al.,
1992). Müller cells can inform immune cell function, and in some cir-
cumstances glial cells may be profoundly immunosuppressive (Caspi
et al., 1987). Many of the responses that are seen in gliosis are ste-
reotypical alterations, that are independent of cause (Bringmann et al.,
2006), but glial cells both produce and respond to inﬂammatory cyto-
kines of innate and adaptive immune response origin (Bringmann et al.,
2009). Müller cells are a source of the proinﬂammatory cytokine IL-8,
that promotes neutrophil recruitment to sites of inﬂammation
(Bringmann et al., 2009). Neutrophils are also an important component
of the inﬂammatory inﬁltrate early in the course of EAU (Kerr et al.,
2008b). In late stages of gliosis, Müller cell processes can form glial
scars in the sub-retinal space, that inhibit photoreceptor regeneration.
This undesirable outcome highlights the dual nature of Müller cells.
Essential for neuronal health, but capable of driving irreversible ana-
tomical changes (Bringmann et al., 2006). A key component of this
process is the presence of activated microglia, which produce neuro-
trophic factors that modulate Müller cells and modify their support of
photoreceptors, inﬂuencing the balance between regeneration and
apoptosis (Harada et al., 2002). Isolated astrocytes are themselves also
able to activate uveitogenic T cells (Jiang et al., 2008) and there is some
evidence that they may respond to the cytokine microenvironment
diﬀerently than RPE cells (Ke et al., 2009). It is clear that cells origi-
nating in the local environment can interact with accumulating immune
cells.
More subtle examples of reorganisation are recognised when in-
ﬂammation is less marked but not completely resolved. Under these
circumstance there may be movement of the microglia and recruited
macrophages to the subretinal space, where they are retained rather
than being cleared by normal homeostatic processes (Guillonneau et al.,
2017). These changes in location are sometimes associated with
changes in function, for example upregulation of the phagocytic and
antigen processing capability of these cells. By such changes the ability
of the tissue to interact with the adaptive immune system can be subtly
enhanced, altering the likelihood of full activation.
2.3. Local scale and scope
One explanation for the reorganisation of immune cells in immune
privileged tissues is that this allows a local response tailored to stimuli
within the tissue. It raises questions about what these signals are and
how autonomous they might be. Regulation of immune cell retention in
tissues depends on the integration of signals from cell surface receptors
that interact with soluble and cell surface ligands. These signals mod-
ulate many diﬀerent aspects of cell function including activation state,
location, motility, metabolism and diﬀerentiation. But are the mole-
cular cues that regulate these processes local or systemic in nature?
Should we envision immune reorganisation as arising in response to
global instruction, or is a better model a series of loosely co-ordinated
independent expressions of antigen speciﬁc immunity?
The shortest distance over which eﬀector functions act is between
one cell and its neighbour. The exquisite speciﬁcity that can be
achieved has been nicely demonstrated for CD8+ T cell killing, where
within a skin graft composed of a mixture of MHC haplotypes, only
those cells that elicit an allogeneic immune response are killed while
non-allogenic neighbours survive (Rosenberg and Singer, 1988). These
cell-cell contact dependent events rely on the focused release of cyto-
toxic molecules.
Studies directed at determining the maximum distance over which
cytokines elicit eﬀector functions have demonstrated that they can
work over quite diﬀerent scales. Some investigators have highlighted
the importance of directional secretion of cytokines into the synaptic
cleft (Huse et al., 2006; Sabatos et al., 2008), while others have pro-
vided evidence that cytokines determine cell fate throughout a whole
lymph node (Olekhnovitch et al., 2014; Perona-Wright et al., 2010).
Soluble eﬀector molecules can co-ordinate acute tissue responses in
other ways. The range over which signalling by interferon-gamma
(IFNγ) to macrophages establishes a killing zone is more than 80 μm
from the activated T cells (Müller et al., 2012). Then the high levels of
nitric oxide (NO), produced in response to IFNγ signalling stimulated by
intracellular Leishmania infection, entrains the elimination of parasites
whether or not the individual macrophages have the capacity them-
selves to produce NO. This was shown by studying mixtures of cells
competent or not competent for NO production: As enough NO becomes
available throughout the tissue the individual phenotype of the mac-
rophage is irrelevant to pathogen destruction (Olekhnovitch et al.,
2014). NO is also seen to be acting at a distance in EAU, and as well as
activating macrophage/microglia, it is one of a number of eﬀector
molecules that limit the local proliferation of T cells (Raveney et al.,
2009, 2010).
How soluble molecules have action at a distance, called ‘scaling
eﬀects’, have been studied in other areas of cell biology. In develop-
ment, ‘source-sink’ models have been explored since the 1970s to ex-
plain the generation of morphogen gradients (Rogers and Schier, 2011).
A recent report applying these concepts to cytokines such as IL-2 illu-
minate the application of this principle in the immune system, focusing
on the balance between diﬀusion and consumption. In these experi-
ments, the density of cytokine receptor bearing cells, which can remove
cytokines from the environment, determines the distance over which
the cytokines act (Oyler-Yaniv et al., 2017). This work highlights how
dynamic microenvironments can be, with their size changing in relation
to the amount of cytokine and the density of cytokine consuming cells.
This volume can be modelled as a sphere with a radius that varied from
30 to 150 μm. Interestingly, this would produce a local microenviron-
ment on a similar scale to those found in follicles measured in human
tonsils (Crocker et al., 1983; Gorﬁen et al., 1999). But smaller niches
have also been described, for example, stem cell niches in Drosophila
which have recently been reported to have a radius of 25 μm (Liang
et al., 2017).
2.4. Antigen driven Re-programming
The observation that leukocytes can be obtained from the retina of
animals following acute EAU in numbers that far exceed those obtained
from healthy animals, or from animals immunized with non-ocular
antigens, attests to the changes that the disease process imprints on the
local tissue (Table 1). The organisation of these cells in animals and
humans varies enormously, from diﬀusely scattered inﬁltration,
through perivascular accumulations, to structures that resemble orga-
nised lymphoid follicles (Chu et al., 2016; Kielczewski et al., 2016;
Kleinwort et al., 2016; Murray et al., 1990). The most likely principle
driver of this is ongoing antigen presentation. What is the evidence that
autoantigens are still present in late disease?
It is known that in EAU there is strain and species associated
variability in the degree of photoreceptor destruction (see for example
(Chen et al., 2012; Oh et al., 2011)) and in human studies very little
retinal tissue may be apparent in end stage disease. Likewise, in some
rodent models, complete destruction of the retina has been reported. On
the other hand, in the C57BL/6 model of EAU, photoreceptors are
preserved at least as late as 120 days after immunisation (Chen et al.,
2012). In diseases such as type I diabetes, where it had long been be-
lieved that pancreatic beta-cell destruction is complete, this view has
been revised. In sensitive evaluations of insulin C-peptide production,
evidence has been found for ongoing cell regeneration, long after the
onset of clinical disease (Wang et al., 2012). Complete destruction of a
target tissue to a level where there is no autoantigen presentation is
therefore less common than has been appreciated, and frustrated at-
tempts at regeneration may be a long-term source of autoantigen
(Casciola-Rosen et al., 2005).
Immunoregulation also serves to preserve the source of autoanti-
gens. In both infection and autoimmunity, despite the continued pre-
sence of antigen, the immune response has capacity to down-regulate
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local tissue inﬂammation and target tissue destruction. The literature
identiﬁes a number of diﬀerent mechanisms including the development
of tissue speciﬁc T regulatory cells (Tregs) (Rosenblum et al., 2011) and
the presence of antigen presenting cells whose ability to initiate T cell
activation is constrained (Nicholson et al., 2009; Raveney et al., 2010).
In keeping with these observations, in models of persistent infection, for
example herpes simplex viral infection of the trigeminal nerve, the local
response to infected cells is exquisitely balanced between dominant and
sub-dominant CD8+ T cell populations and between active and sub-
clinical inﬂammation in both mice and humans (St Leger et al., 2013;
St. Leger et al., 2011; Verjans et al., 2007).
The multiparameter analyses that have facilitated more compre-
hensive quantiﬁcation of recruited cell populations in studies of ocular
autoimmunity, have revealed complexity in both immune cell type and
cell dynamics in the aﬀected tissue. Many diﬀerent lymphocytes can be
detected (Fig. 1), some of which have relatively short tissue half-lives,
some of which are resident in tissue for much longer (Boldison et al.,
2014). It is to be anticipated that during secondary regulation this
variety of cell phenotypes have a broad range of diﬀerent functions, but
one organising observation, based on the expression of diﬀerent im-
mune relevant coinhibitory-receptors, and the accumulation of Tregs, is
a shift from a tissue tolerating immune activation to one resisting it.
The substantial diﬀerence in immune cell recovery from the eyes of
animals after they have developed clinical EAU, compared with age
matched naive controls, argues strongly against the proposition that
during secondary regulation, the tissue returns to a state that is
equivalent to that pre-disease. Diﬀerent lymphocyte populations show
distinct and diﬀerent patterns of accumulation and dynamics in terms
of recirculation. Furthermore the retina is not the only compartment
altered by the disease process, as in EAU the bone marrow has been
identiﬁed as a source of CD4+ T cells that mediate chronic uveitis (Oh
et al., 2011).
2.5. Changes in matrix and supporting cells
Of the many cell types involved in tissue remodelling, the least is
known about changes in the supporting stromal tissue that contribute to
the niches that the inﬁltrating immune cells occupy. There are sig-
niﬁcant changes in cell matrix is some models of uveitis. In equine
recurrent uveitis, levels of ﬁbronectin and osteopontin in the vitreous
fall, and this is accompanied by deposition of ﬁbronectin deeper in the
retina, and the almost complete disappearance of osteopontin (Deeg
et al., 2011). Data is scarce on stromal cells in the matrix in persistent
uveitis, although exogenously derived mesenchymal stem/stromal cells
have been reported to protect from EAU by a CCL2-dependent re-
cruitment of myeloid-derived suppressor cells (Lee et al., 2015).
Retinal pigment epithelium (RPE) cells have been investigated ex-
tensively. There is good evidence for them playing an important role in
sustaining ocular privilege (Ferguson and Griﬃth, 2006; Stein-Streilein,
2013; Sugita, 2009; Sugita and Streilein, 2003). Many mediators that
play a role in this process have been described; some are soluble factors,
while others are contact dependent. RPE cells can activate and repro-
gram lymphocytes, driving the development of Tregs (Sugita et al.,
2006, 2008) and macrophages, inducing cells resembling myeloid de-
rived suppressor cells (Tu et al., 2012). These important ﬁndings have
also been translated to clinical studies (Mandai et al., 2017; Sugita
et al., 2016).
The role of the RPE in the face of persistent inﬂammation is not as
clear. In models of AMD, modulation of autophagy can have eﬀects on
inﬂammasome activation (Liu et al., 2016). Culture of RPE cells with
inﬂammatory mediators such as interferon-gamma does not abrogate
their ability to suppress immune responses (Sugita, 2009), but this
ability is clearly insuﬃcient to prevent the development of leukocyte
inﬁltration and disease in EAU. Although the expression of Fas ligand is
a prominent feature of eye tissue, deﬁciencies in this cell death indu-
cing pathway does not cause spontaneous uveitis. Instead, the absence
of this control mechanism exacerbates disease that is induced by con-
ventional means (Ferguson and Griﬃth, 2006). RPE cells produce fac-
tors such as IL-33, that modulate uveitis through the disease course
(Barbour et al., 2014; Theodoropoulou et al., 2017), but it has also been
reported that the production of inﬂammatory stress can damage the
RPE by mechanisms that depend on IL-6 and IL-8 signalling (Leung
et al., 2009; Planck et al., 1992), perhaps rendering them less eﬀective
functionally.
IL-6 has been identiﬁed as an important inﬂammatory cytokine in a
number of diﬀerent inﬂammatory eye diseases (Ohta et al., 2000). In
endotoxin induced inﬂammation IL-6 antagonises the eﬀects of TGF-
beta (Ohta et al., 2000), and blocking IL-6 suppresses EAU (Haruta
et al., 2011). This work has led to studies of IL-6 blockade in patients.
3. Cells and structures
3.1. CD4+ T cells
EAU is known to be CD4+ T cell dependent, because transfer of
activated retinal autoantigen speciﬁc CD4+ T cells into a naive host is
suﬃcient to induce disease (Caspi, 2010). The evolution of pathology
depends on these cells crossing the BRB which both in rats (Prendergast
et al., 1998) and mice (Xu et al., 2003) is facilitated by T cell activation
and can occur independent of antigen speciﬁcity. In diﬀerent EAU
models both Th1 and Th17 cells have been shown to cause disease
(Luger et al., 2008). Following immunisation with retinal antigens, the
accumulation of small numbers of CD4+ T cells in the retina is de-
tectable in the preclinical phase of disease, although their precise
anatomical site is not well deﬁned (Kerr et al., 2008b). CD11b+
monocytes and smaller numbers of Ly-6G+ neutrophils also accumulate
with kinetics that are indistinguishable from the CD4+ cells. The
techniques used to identify these cells (ﬂow cytometry of disaggregated
tissue) do not distinguish between cells arrested in the tissue bound to
blood vessel endothelium and cells deeper within tissues. In lung tissue
it has been demonstrated that perfusion does not remove these cells
from the tissue (Anderson et al., 2012), so the precise location of cells
identiﬁed following tissue disaggregation remains an open question.
The relative frequencies of diﬀerent cell populations that contribute
to disease is regulated by the cytokine and chemokine milieu. Early in
disease, it is changes in the BRB and the local expression of a number of
diﬀerent chemokines and their receptors that enable the entry of cells
into the tissue (Crane and Liversidge, 2008), while the expression of
CD62L and CD44 also play a critical role in directing blood monocyte
traﬃcking (Xu et al., 2008). In animals deﬁcient in IFNγ, disease still
occurs but there is an increase in the neutrophil content of the in-
ﬁltrating population compared with monocytes, which is associated
with more profound tissue damage (Su et al., 2007). In a transgenic
model where antigen was injected directly into the eye, CXCR4 (but not
CXCR7) was critical for ocular leukocyte traﬃcking leading to acute
uveitis (Zhang et al., 2009). Less is known about the mechanisms that
retain cells within the retina in the long term.
Chronic inﬂammation in other tissues such as the skin and lung have
been characterised more extensively and these ﬁndings may be relevant
to chronic autoimmune inﬂammation in the eye. In models of delayed
type hypersensitivity, after cells have accumulated, the chemokine re-
ceptor CCR7 plays an essential role in the early egress of lymphocytes
from tissue (Bromley et al., 2005). Later in the course of inﬂammation
CCR7 independent exit mechanisms also come in to play (Brown et al.,
2010). One pathway which has been characterised is the regulation of
the sphingosine-1-phosphate (S1P) receptor 1 by CD69. The upregula-
tion of CD69 inhibits cells’ ability to sense gradients of S1P that provide
cues for directed exit from a tissue. Other less well characterised me-
chanisms can be inhibited by pertussis toxin, therefore likely involving
Gαi-coupled receptor signalling. These changes in the mechanisms by
which CD4+ T cells are retained within niches in tissues are accom-
panied by alterations in the rate at which lymphocytes traﬃc out of
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tissues. In sheep and mice, when inﬂammation is chronic, there is an
increase in the rate at which cells exit tissues (Brown et al., 2010). The
important relevance of these studies to uveitis (Boldison et al., 2014;
Chen et al., 2012; Copland et al., 2012; Oh et al., 2011; Raveney et al.,
2008) is that re-programming under chronic inﬂammation remains a
dynamic process at late stages of disease, with recirculation of CD4+
cells, changes in the composition of inﬁltrating immune cells and
changes in their rates of recirculation.
3.2. CD8+ T cells
Antigen speciﬁc cytotoxic CD8+ T cells are a critical part of the
immune response to many intra-cytoplasmic pathogens, especially
viruses. In the mouse, viral infections provoke the expansion of re-
sponder cells but also the generation of memory cells. Populations of
these memory cells are distributed to diﬀerent organs where they be-
come long-lived tissue resident cells (Klonowski et al., 2004; Sheridan
and Lefrancois, 2011). The distribution to diﬀerent organs is not uni-
form, and immune privileged tissues are resistant to the accumulation
of memory cells following systemic infection, although they are an
important component of the response to local infection (Schenkel and
Masopust, 2014; Wakim et al., 2010, 2012). For example, CD4+ T cell
help regulates the mobilization of CD8+ T cells to the vaginal cavity
(Nakanishi et al., 2009) and detailed quantiﬁcation of tissue resident
CD8+ T cells demonstrated regionalised immunosurveillance (Steinert
et al., 2015). CD8+ T cells are recognised to play a role in many dif-
ferent autoimmune diseases, including diabetes and diseases that aﬀect
the central nervous system (Goverman, 2009; Santamaria, 2010).
Retinal antigen speciﬁc CD8+ T cells obtained from the periphery of
animals with uveitis have been studied and both pathogenic and reg-
ulatory roles have been reported. They play an important role in ACAID
where they act as eﬀerent inhibitors of uveitis, able to restrict disease
even when it has become established (Hsu et al., 2014; Keino et al.,
2006; Lin et al., 2005; Peng et al., 2006, 2007; Shao et al., 2005).
CD8+ T cells that are obtained from the retina are phenotypically
heterogeneous (Boldison et al., 2014). Unlike CD4+ T cells which
achieve their highest density of inﬁltration early in EAU, CD8+ T cells
continue to accumulate as the disease progresses; the number of CD8+
T cells that are recovered from retinas in late disease varies with strain
and is greater in C57BL/6 animals compared with B10.RIII ((Boldison
et al., 2014) and unpublished data). In the C57BL/6 mouse CD8+ T
cells numbers double between day 21 (peak) and day 42 (secondary
regulation). Depleting CD8+ T cells before immunisation did not
change the course of EAU in rats (Calder et al., 1993) but peripheral
depletion at late stages of disease in mice clears these cells from the
retina and leads to an increase in cellular inﬁltration by CD4+ T cells
and CD11b+ macrophages, implying that the presence of CD8+ T cells
limited the accumulation of other leukocytes (Boldison et al., 2014).
The molecular mechanisms that regulate the process of counter reg-
ulation are yet to be understood.
Phenotyping CD8+ T cells in the retina by ﬂow cytometry during
inﬂammation reveals that most (> 90%) have characteristics of eﬀector
memory (CD44hiCD62Llow). As disease progresses about half of the
CD8+ T cells show an increased expression of the co-inhibitory receptor
PD-1, which is a key signature of the exhaustion program of CD8+ T
cells (Wherry, 2011). The part that this inhibitory costimulatory
pathway plays in EAU is currently uncertain. Treatment of mice and
humans with reagents that block its action are known to exacerbate
clinical disease, (J. Boldison and A. Dick personal communication), and
this is likely to be an important practical consideration when targeting
co-inhibitory receptors for the treatment of human tumours (Antoun
et al., 2016).
Because a substantial fraction of CD8+ T cells do not express PD-1,
this raises the possibility of diversity of function of the CD8+ T cells in
the microenvironment of the intracellular inﬁltrate, perhaps relating to
the antigen speciﬁcity of the cells. In the C57BL/6 strain, we do not
detect the expression of Foxp3 or IL-10 expression by CD8+ T cells,
arguing against an important role for STAT3 modulated IL-10 produ-
cing CD8+ T cells in this model of disease ((Yu et al., 2013) and J.
Boldison unpublished data).
The relevance of CD8+ phenotype to human ocular disease goes
beyond the role that it plays in the ocular environment. Studies of
CD8+ T cells obtained from peripheral blood have shown that inter-
rogating these cells can be used as part of a novel diagnostic strategy to
distinguish sarcoidosis from Behcet's disease (Candia et al., 2013) al-
though the relationship between tissue resident and circulating CD8+ T
cells remains to be elucidated. CD8+ T cell phenotype is also an im-
portant prognostic consideration in other autoimmune diseases
(McKinney et al., 2010, 2013, 2015).
The signals that deﬁne the niche that CD8+ T cells occupy in au-
toimmune disease are not as well characterised as those that regulate
tissue accumulation following infection. One feature of these antigen
speciﬁc tissue resident memory CD8+ T cells that accumulate following
the clearance of an acute viral infection is the upregulation of the in-
tegrin CD103. In EAU, CD103 is not upregulated, yet memory CD8+ T
cells are retained in the tissue. As for CD4+ T cells, another candidate
for the molecular regulation of cell exit is CD69. CD8+ T cells in the
tissue express high levels of CD69 which limits lymphocytes’ ability to
use signals from S1P gradients to regulate traﬃcking into the circula-
tion. Therefore, the niche could be deﬁned by an inability to escape,
rather than by an invitation to stay.
3.3. B cells and ectopic lymphoid-like structures
The role of B cells in non-infectious uveitis has not been as ex-
tensively studied as that of the T cell or myeloid cell (either in ex-
perimental uveitis or human uveitis) although interest in the B cell with
respect to uveitis is increasing (Smith et al., 2016). B cells are detected
in small numbers in the retinas of animals with EAU and their numbers
increase late in disease (Boldison et al., 2014). In EAU, as in other
autoimmune diseases, it has recently been established that IL-10 pro-
ducing and IL-35 responsive B cells can modulate the progression of
disease (Shen et al., 2014; Wang et al., 2014), but a role for B cells
within the tissue remains unclear.
The limited data on the immune cell inﬁltrate – and the develop-
ment of tissue niches - in human uveitic eyes is due to the lower in-
cidence of uveitis compared to other autoimmune disorders (e.g.
rheumatoid arthritis), and the technical diﬃculties of chorioretinal
biopsy. Only small amounts of uveitic ocular tissue have been available
for study. B cells are certainly a component of human disease: an im-
munohistochemical study of a single enucleated eye from a patient with
juvenile idiopathic arthritis-associated uveitis demonstrated focal ag-
gregates of CD20+ cells in the ciliary body (Parikh et al., 2008).
This report is now complemented by further data (Epps et al.,
manuscript in preparation), which characterises the immune cell in-
ﬁltrate in 15 human eyes obtained from individuals with severe non-
infectious uveitis (Anterior 1; Intermediate 1; Posterior 2; Panuveitis
11). B cells and T cells were detected in the majority (11 out of 15 cases
[73%]) of cases (Fig. 2A). In 3 out 15 eyes (20%), there were clear
features of ectopic lymphoid-like structures (ELS) (Fig. 2B). It was
possible to identify focal aggregations of CD20+ B cells and CD3+ T
cells (consisting of a mixed CD4+ and CD8+ population) with the
segregation of lymphocytes into adjacent but distinct T and B cell zones
(Fig. 2). CD21+ follicular dendritic cell (FDC) networks were present
and there was evidence of the germinal centre reaction, (B cell lym-
phoma 6 protein (BCL6) and/or activation-induced cytidine deaminase
(AID) expression within the CD20+ areas). Within a single eye, ELS of
diﬀerent degrees of maturity were observed, consistent with the local
regulation of individual structures, rather than global co-ordination,
and supporting the view that ELS are dynamic structures which develop
and dissipate during the course of a chronic disease process, which has
also been reported in rheumatoid arthritis (van de Sande et al., 2011).
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The fact that only a proportion of patients in this series – as in other
studies of non-ocular tissues aﬀected by chronic inﬂammation - devel-
oped features of ELS, may reﬂect underlying diﬀerences in the local
inﬂammatory microenvironment predisposing towards or acting
against the development of ELS (Jones et al., 2016). The small size of
the series and limited access to other relevant information, such as HLA
type, preclude more extensive mechanistic conclusions. The ocular
structures that are involved extend beyond the retina, which is often the
focus of analysis in acute EAU, and this may reﬂect important diﬀer-
ences between chronic human disease and the more limited nature of
most studies using EAU as a model.
The small numbers of lymphocytes found within the retina in
human disease contrasts with the data of Kielczewski et al. (2016) de-
scribing ELS lesions in an EAU model driven by an antigen speciﬁc T
cell receptor (TCR) transgenic mouse (the R161H mouse (Kielczewski
et al., 2016)). In this model ELS is predominantly in the retina. Because
TCR transgenesis leads to large numbers of T cells with speciﬁcity for a
single retinal antigen, whereas disease following immunisation or in
human uveitis is likely driven by a more diverse T cell population, such
diﬀerences may impact the location of ELS. The anatomy of the choroid
also diﬀers between mouse and human: the choroid is relatively much
thicker in the human eye and might provide a more permissive stromal
microenvironment for the development of ELS. A caveat though is that
the choroid is not well characterised in murine EAU.
The ﬁnding of ELS in the choroid in human uveitis has parallels with
multiple sclerosis (MS), where ELS have been demonstrated within the
dura mater of the meninges not the neural brain parenchyma
(Magliozzi et al., 2007). Like the dura, the choroid is a highly vascu-
larized structure containing abundant stromal ﬁbroblasts which play a
pivotal role in orchestrating the development of ELS (Buckley et al.,
2015). Both structures are adjacent to a source of autoantigens (i.e. the
neural retina and neural brain parenchyma), although it should also be
borne in mind that the retina was severely damaged by the disease
process in many of these samples and little retinal tissue remained.
Stromal cells in the choroid (such as ﬁbroblastic reticular cells and
blood endothelial cells) could play an important role in the recruitment
and retention of immune cells. In chronic CNS inﬂammation, meningeal
stromal cells upregulate secretion of the lymphoid chemokines, in-
ﬂammatory cytokines and adhesion molecules (e.g. CXCL13; lympho-
toxin, IL-17, IL-22; ICAM-1), mediating the recruitment and retention of
immune cells into the CNS (Buckley et al., 2015; Columba-Cabezas
et al., 2006; Pikor et al., 2015). In a subset of cases of chronic neu-
roinﬂammation, this leads to the formation of an immune-competent
niche with structural compartmentalisation and the development of ELS
(Choi et al., 2012; Gardner et al., 2013; Howell et al., 2011; Magliozzi
et al., 2007, 2010).
In MS and its experimental model experimental autoimmune en-
cephalomyelitis (EAE), immunoglobulin class-switched (and therefore
antigen-experienced) B cell accumulations occur surrounding CD21+
CD35+ CXCL13+ stromal cells, a phenotype resembling FDCs
(Magliozzi et al., 2007; Peters et al., 2011). The role of FDCs in lym-
phoid tissue in capturing antigen and presenting it to B cells to generate
a germinal centre response is well-recognised (Heesters et al., 2014),
and it can be surmised that these FDC-like stromal cells within the
meninges perform the same function, resulting in the production of
mature autoreactive B cells (memory B or plasma cells) in the target
tissue, distant from central immune tolerance mechanisms, thus po-
tentially exacerbating and perpetuating the chronic disease process
(Magliozzi et al., 2007; Peters et al., 2011). In MS, a gradient of neu-
ronal loss and demyelination is seen within areas of the cerebral cortex
adjacent to sites of meningeal ELS formation, with more profound ab-
normalities occurring immediately proximal to the ELS and less marked
abnormalities distally (Magliozzi et al., 2010). It is plausible that a si-
milar scenario occurs in uveitis, with organised lymphoid tissue-like
niches developing within the choroid adjacent to the neural retina, and
thereby contributing to retinal pathology through the recruitment and
retention of leukocytes.
B cells and stromal cells are not the only players in the formation of
ELS. It is evident that Th17 cells play a pivotal role in the formation of
ELS in EAE (Peters et al., 2011). Human meningeal post-mortem sam-
ples obtained from patients with a history of MS demonstrate an in-
creased prevalence of RORγt+ lymphocytes in meningeal ELS compared
to meninges displaying a diﬀuse inﬂammatory inﬁltration, implicating
Th17 and/or group 3 innate lymphoid cells (ILS) in ELS formation
(Seraﬁni et al., 2016). Furthermore, in the EAE model ELS formation is
not restricted to inﬂammation characterised by T cells of the Th17
compartment; adoptive transfer of Th1 or Th17-skewed cells resulted in
the development of comparable levels of ELS formation (Pikor et al.,
2015). Similarly, a CD4+ and CD8+ T cell inﬁltrate in addition to
CD68+ macrophages and CD138+ plasma cells were evident in the data
of Epps et al. from human uveitis.
The signiﬁcance of ELS-like structures within the eye with respect to
regulation or autoimmunity remains to be determined. Kielczewski's
work on EAU (2016) correlates ELS with retinal function, with aﬀected
eyes having lower clinical signs of retinal inﬂammation initially as well
as slower disease progression, as measured by electroretinography
(Kielczewski et al., 2016), but losing this advantage as disease pro-
gresses. This contrasts with the majority of data on ELS in human au-
toimmunity, where ELS are associated with, for example, the genera-
tion of autoantibodies (Humby et al., 2009), a poorer clinical response
to anti-TNF therapy in rheumatoid arthritis (Canete et al., 2009) and a
worse clinical prognosis in secondary progressive multiple sclerosis
(Magliozzi et al., 2007). This certainly raises the possibility that the
presence of ELS in human uveitis may be associated with a worse
clinical prognosis. There is emerging data that anti-B cell therapies may
ameliorate human uveitis (Lasave et al., 2017), which is consistent with
the B cell microenvironment of the ELS playing a pathogenic role in
uveitis.
Further mechanistic data from experimental models is required to
deﬁnitively establish the function of ELS within the ocular micro-
environment in the context of chronic inﬂammation. In conjunction
with such data, methods of establishing the presence of ELS and the
dynamics of their development within the eye in vivo during uveitis are
required: sampling ocular ﬂuids for gene and protein expression pat-
terns consistent with development of ELS and in vivo imaging exploiting
enhanced depth imaging of the choroid and anterior segment imaging
by optical coherence tomography (OCT) and potentially in vivo label-
ling of lymphocytes opens this possibility. Thus, the evidence of tissue
re-programming seen in chronic immune activation within the human
eye – both in the form of immune cell spatial reorganisation into B cell
follicle-like structures and vascular re-programming - results in the
formation of a potential niche for antigen-speciﬁc B cell proliferation,
mutation, selection and maturation, B-T cell interactions, and could be
of clinical relevance with respect to B-cell immunomodulatory thera-
pies in uveitis.
3.4. Neutrophils
Although neutrophils are best known as acute pro-inﬂammatory
responders, they have also been implicated in tissue surveillance, re-
sponding to pertussis toxin-sensitive signals (Ng et al., 2011). Neu-
trophils identiﬁed by their expression of Ly-6G are not found in the
normal retina. However, they can be detected early in the disease
prodrome and in the B10.RIII uveitis model peak at the same time as
CD4+ IL-17 expression (Kerr et al., 2008b). This pattern is not seen in
C57BL/6 animals where Ly-6G positive cells continue to be detected at
similar low levels (< 1000 cells) through to late time points in the
disease course (J. Boldison, unpublished data). Gr-1 positive cell re-
cruitment is regulated by G-CSF via CXCR2 and CXCR4 and targeting
this cytokine leads to a selective deﬁcit in Gr-1 positive cells and re-
duced EAU (Goldberg et al., 2016). Genetic ablation of IFNγ ex-
acerbated clinical EAU and was associated with a marked increase in
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the accumulation of granulocytes. There was an altered pattern of
dominant chemokine expression (CCL1, 11, 17, 22 and CXCL2 in the
IFNγ knockouts and CXCL9, 10, 11 and CCL5 in wild type disease) and
granulocyte depletion ameliorated disease (Jones et al., 1997; Su et al.,
2007).
3.5. Microglia and macrophages
Flow cytometry analysis of the normal retina identiﬁes a population
of fewer than 1000 CD11b+ cells (Table 1). These cells are resident
microglia (Hughes et al., 2003; Liu et al., 2013). In healthy tissue,
microglia form ramiﬁed networks in which individual cells have a
limited location within which they move to survey the environment
(Luckoﬀ et al., 2017; McMenamin, 1999). In models of several diﬀerent
ocular disease, these cells relocate. As indicated above, following in-
jury, infection and danger signals, they move to the subretinal space
and some assume a more amoeboid form that becomes a common
component of the recruited cell population (Chinnery et al., 2015; Ng
and Streilein, 2001; Zinkernagel et al., 2013). Microglial accumulation
in the subretinal space (Karlstetter et al., 2010) is also a feature of the
aging retina, reinforcing that this process is part of a general response
mechanism to stress. Relocation is regulated by cytokines, chemokines
and signalling receptors (Carter and Dick, 2004; Luhmann et al., 2012)
that direct cell migration, and this occurs in human explants as well as
murine systems. The expression of other molecules may also be im-
portant in this process and future research is likely to reveal other
important mechanisms.
Monocyte/macrophage activation is controlled by both positive and
negative signals from the local environment. One important receptor
that delivers a negative signal to these cells is the CD200R, which plays
a role in modulating inﬂammation under a wide range of pathologies
(Gorczynski et al., 2010; Jenmalm et al., 2006; Snelgrove et al., 2008).
The ligand for CD200R is widely expressed and has also been co-opted
by a number of diﬀerent viruses to which it presumably imparts an
advantage (Barclay et al., 2002). In the eye the role of CD200/CD200R
in the control of the local environment extends beyond just regulation
of inﬂammation (Broderick et al., 2002; Copland et al., 2007) to the
control of other functions such as angiogenesis (Horie et al., 2013).
In EAU in C57BL/6 mice, myelomonocytic cells, visualised with
various ﬂuorescent reporters, accumulate around the optic nerve head
and along retinal vessels. They are clearly present by day 14 post-im-
munisation (Chen et al., 2015). As uveitis develops, there is an in-
creasing contribution of CD11b+ cells recruited from the circulation;
their ablation can prevent the development of clinical disease, an eﬀect
that is partly mediated by the reduction in NO (Forrester et al., 1998;
Hoey et al., 1997). The phenotype of macrophages in the circulation
diﬀers signiﬁcantly from those that accumulate in the retina which
upregulate Gr-1 (Kerr et al., 2008b). The recirculation of these mono-
cytes is inhibited by blocking CD44 or CD62L (Xu et al., 2008) and
unlike CD4+ T cells their recruitment is conditioned by activation
through the TNFR1, because in mixed chimeras of TNFR1 expressing
and non-expressing macrophages, only the cells that express TNFR1
accumulate in the retina (Raveney et al., 2009). On the other hand,
their expression of CCR2 is dispensable to the development of disease
(Dagkalis et al., 2009). When monocyte/macrophages are puriﬁed from
the eye at the peak of disease, they are found to support antigen speciﬁc
activation of cytokine secretion by T cells, but they restrict T cell pro-
liferation which is inhibited through NO and PGE2 dependent me-
chanisms. This serves to produce a microenvironment in which energy
that would otherwise be used for T cell division, is available to other
eﬀector cells such as activated macrophages and neutrophils (Raveney
et al., 2010). There are other circumstances in which T cells can pro-
liferate within the ocular environment. Naive transgenic T cells, that
recognised an ocular autoantigen, and were transferred directly into the
eye both proliferated and expressed a FoxP3 associated GFP-reporter,
indicating that they were of a regulatory phenotype; a similar transfer
into animals with established uveitis did not lead to conversion to a
Treg phenotype and their degree of proliferation was not reported
(Zhou et al., 2012). How changes in the capacity to support local pro-
liferation vary with time and changes in the local environment awaits
further clariﬁcation.
3.6. Angiogenesis
Inappropriate angiogenesis is a source of many diﬀerent types of
ocular pathology. It is regulated by a large number of soluble factor
such as the VEGF family (Nagy et al., 2007), Lrg1 (Wang et al., 2013),
thrombospondin-1 (Dipietro and Polverini, 1993) and also receptor
mediated interactions with the chemokine ligands and the extracellular
matrix (Campochiaro, 2015; Chen et al., 2012). In EAU, angiogenic
eﬀectors such as VEGF can disrupt the blood-retinal barrier (Luna et al.,
1997) and although angiogenesis is not a prominent component of
human inﬂammatory eye disease, vascular dysfunction leading to ma-
cular oedema is a common late sight threatening complication (Daruich
et al., 2017; Rothova et al., 1996). Such persistent ocular inﬂammation
is associated with neovascular lesions in a number of diﬀerent mani-
festations of human ocular disease, including choroidal neovascular-
isation and retinal angiomatous proliferation (Dhingra et al., 2010;
Kedhar et al., 2007; Thorne et al., 2006).
In C57BL/6 mice a similar phenotype occurs in the course of EAU
(progressing from around day 60) manifesting as the formation of ret-
inal neovascular membranes (RNM) that extend through the retina and
fuse with the retinal pigment epithelium (RPE) (Chen et al., 2012). This
phenotype has been visualised by photography, OCT and ﬂuorescein
angiography as late as 146 days after the induction of disease
(Fig. 3A–C). At this time, Th17 cell (not shown) and macrophage
(CD11b+) inﬁltration is found associated with the lesions (Fig. 3D–F).
Manipulations that modify the accumulation of leukocytes (knockouts
of CCR2, CCL2xCX3CR1 and TNFR1) or that modify the extracellular
matrix (Thrombospondin-1 knockout) change the severity of RNM an-
giogenesis (Chen et al., 2012; Fordham et al., 2012; Raveney et al.,
2009; Zhao et al., 2014) (T.Khera, M.Stimpson et al. unpublished). This
demonstrates that the nature of the local microenvironment informs the
development of the new vessels.
Because expression of TNFR1 is critical for the eﬃcient recruitment
of macrophages in EAU (Raveney et al., 2009), we compared angio-
genesis in persistent uveitis in TNFR1 knockout and C57BL/6 WT ani-
mals 90 days after the induction of disease, and found that there was a
striking diﬀerence in the phenotype of the vascular changes (Fig. 3G
and H). At this time point, the retinas of both strains are heavily in-
ﬁltrated with leukocytes, compared to normal age-matched animals.
Total cell numbers are lower in the knockout mice, but the ratio of
CD4+:CD11b+ cells is the same in both strains. When the cytokine
content of the retinas was assessed by measuring RNA, IL-17 but not
IFNγ levels were decreased in the TNFR1 knockouts (T.Khera,
M.Stimpson et al. unpublished). This shows that diﬀerent patterns of
cytokine signalling, that impact on the phenotype of recruited macro-
phages, can modulate the nature of the local microenvironment and
inﬂuence the development of new vessels. Such macrophages remain a
tractable target for therapy (Lee et al., 2014).
One cellular feature of this persistent ocular inﬂammation, the on-
going presence of macrophages exhibiting an alternative activation
phenotype (Lee et al., 2014) has been implicated in several diﬀerent
aspects of tissue remodelling including angiogenesis. Inﬂammatory and
anti-inﬂammatory cytokines and/or the uptake of damaged RPE can
condition the macrophage to adopt a phenotype that can promote or
limit new vessel growth (Liu et al., 2013; Wu et al., 2010). Acute
conditioning in vitro and in in vivo with the cytokine IL-4 leads to a
macrophage phenotype that inhibits angiogenesis. This occurs through
the upregulation of a decoy receptor that can neutralise vascular en-
dothelial growth factor (VEGF), suﬃcient to suppress the development
of laser-induced choroidal neovascularisation (Wu et al., 2015). This
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work delivers proof of principle for macrophage targeting to modulate
angiogenesis.
4. Summary and future directions
It seems reasonable to propose that the process of local tissue in-
ﬂammation, within an immune-privileged tissue, has re-programmed
immunosurveillance and induced new niches that become occupied by
cells of the immune system. Such a scenario need not imply the dif-
ferentiation of immune cells within the eye, but rather the development
of sites where such cells halt, and where they have an increased dwell
time much greater than that seen in the naive state. These sites might
have a deﬁned anatomical distribution, perhaps associated with the
perivascular space, or their distribution could relate to sites of previous
inﬂammation as seen in CNS tissue (Wakim et al., 2010). The use of
FTY-720, a drug that traps recirculating lymphocytes, to inhibit lym-
phocyte recirculation six weeks after the induction of disease in C57BL/
6 mice, revealed striking diﬀerences in the tissue half-life of CD8+ T
cells compared with CD4+ and CD11b+ cells (Boldison et al., 2014)
and begins to address these issues of diﬀerential traﬃcking and cell
dynamics. Theoretical studies also support the importance of the ki-
netics of cell traﬃcking into regions outside the conventional secondary
lymphoid compartment (Nicholson et al., 2012) as a key factor de-
termining the progress of the disease process. Finally, such niches could
oﬀer attractive therapeutic targets. If local immune surveillance can be
restored to its pre-disease state, local triggering and relapse might be
limited and ongoing tissue damage impeded.
Our future understanding of immune privileged tissue re-program-
ming in uveitis will be facilitated by new technologies which are ad-
vancing rapidly. Tackling the diﬃcult issues of the local organisation of
transient cellular structures will become possible as techniques such as
OCT achieve resolution at the level of individual cells (Drexler et al.,
2014). Complementary studies that can recover and analyse the tran-
scriptome of single cells, from within the tissue microenvironment
(Singer et al., 2016; Stubbington et al., 2016), will allow us to move
beyond low dimensional analysis based on the expression of only one or
Fig. 3. Animals (C57BL/6) were immunized with IRBP 1–20 to induce EAU and clinical disease was monitored by topical endoscopic fundal imaging (TEFI), ﬂuorescein angiography and
optical coherence tomography. At day 146 persistent disease neovascular membranes (white arrows), extending into the retina and fused with the RPE are seen (A–C). The neovascular
membranes in wild type animals are associated with CD11b positive macrophages (D–F) and disruption of collagen IV. Gene manipulations that target macrophage function can modify
the vascular phenotype, for example when C57BL/6 wild type (G) and C57BL/6 TNFR1 (H) knockout animals with persistent EAU were assessed 90 days after the induction of EAU by
preparing retinal ﬂatmounts and staining with collagen IV, confocal microscopy showed more vascular modiﬁcations in the wild type animals. Photography, angiography and OCT were
carried out using TEFI and a micron IV retinal imaging microscope (Phoenix research laboratories). Collagen IV stain used a primary rabbit anti-mouse antibody and secondary staining
with goat anti-rabbit conjugated with AlexaFluor 568 (red E,F) or AlexaFluor 488 (green G,H). Scale bar panel C 100 microns.
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two reporter molecules to whole cell physiology. By examining the
heterogeneity of cells that make up diﬀerent niches we can begin to
understand how these dynamic structures are formed, maintained and
dissolved. One trend, that is already presaged by changes in monocyte
phenotype on relocation from the circulation to the tissue (Kerr et al.,
2008b), is the integration of cell surface phenotype with reprogram-
ming lipid biosynthesis (Wang et al., 2015). The key idea of a dialogue
between the tissue and the immune response will be an increasingly
fertile area for research, as we are better able to discern both sides of
the conversation.
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